Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2011 3
2012 1
2014 2
2015 3
2016 3
2017 5
2018 4
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Drug repurposing from the perspective of pharmaceutical companies.
Cha Y, Erez T, Reynolds IJ, Kumar D, Ross J, Koytiger G, Kusko R, Zeskind B, Risso S, Kagan E, Papapetropoulos S, Grossman I, Laifenfeld D. Cha Y, et al. Among authors: zeskind b. Br J Pharmacol. 2018 Jan;175(2):168-180. doi: 10.1111/bph.13798. Epub 2017 May 18. Br J Pharmacol. 2018. PMID: 28369768 Free PMC article. Review.
Use of genetic technologies to compare medicines.
Kolitz SE, Towfic F, Grossman I, Hayden MR, Zeskind B. Kolitz SE, et al. Among authors: zeskind b. Clin Genet. 2014 Nov;86(5):441-6. doi: 10.1111/cge.12462. Epub 2014 Sep 8. Clin Genet. 2014. PMID: 25046029 Review.
A primer on applying AI synergistically with domain expertise to oncology.
Kim J, Kusko R, Zeskind B, Zhang J, Escalante-Chong R. Kim J, et al. Among authors: zeskind b. Biochim Biophys Acta Rev Cancer. 2021 Aug;1876(1):188548. doi: 10.1016/j.bbcan.2021.188548. Epub 2021 Apr 24. Biochim Biophys Acta Rev Cancer. 2021. PMID: 33901609 Free article. Review.
A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".
Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Thurin M, Trinchieri G, Wang E, Wigginton J, Chaussabel D, Coukos G, Dhodapkar M, Håkansson L, Janetzki S, Kleen TO, Kirkwood JM, Maccalli C, Maecker H, Maio M, Malyguine A, Masucci G, Palucka AK, Potter DM, Ribas A, Rivoltini L, Schendel D, Seliger B, Selvan S, Slingluff CL Jr, Stroncek DF, Streicher H, Wu X, Zeskind B, Zhao Y, Zocca MB, Zwierzina H, Marincola FM. Butterfield LH, et al. Among authors: zeskind b. J Transl Med. 2008 Dec 23;6:81. doi: 10.1186/1479-5876-6-81. J Transl Med. 2008. PMID: 19105846 Free PMC article.
Lebrikizumab treatment in adults with asthma.
Zeskind B. Zeskind B. N Engl J Med. 2011 Dec 22;365(25):2432; author reply 2433-4. doi: 10.1056/NEJMc1112234. N Engl J Med. 2011. PMID: 22187992 No abstract available.
Pridopidine activates neuroprotective pathways impaired in Huntington Disease.
Geva M, Kusko R, Soares H, Fowler KD, Birnberg T, Barash S, -Wagner AM, Fine T, Lysaght A, Weiner B, Cha Y, Kolitz S, Towfic F, Orbach A, Laufer R, Zeskind B, Grossman I, Hayden MR. Geva M, et al. Among authors: zeskind b. Hum Mol Genet. 2016 Sep 15;25(18):3975-3987. doi: 10.1093/hmg/ddw238. Epub 2016 Jul 27. Hum Mol Genet. 2016. PMID: 27466197 Free PMC article.
IL-6 and ovarian cancer--letter.
Locasale JW, Zeskind B. Locasale JW, et al. Among authors: zeskind b. Clin Cancer Res. 2011 Dec 15;17(24):7837; author reply 7838. doi: 10.1158/1078-0432.CCR-11-2170. Epub 2011 Dec 6. Clin Cancer Res. 2011. PMID: 22147939 No abstract available.
Letter to the Editor response: Nygaard et al.
Towfic F, Kusko R, Zeskind B. Towfic F, et al. Among authors: zeskind b. Biostatistics. 2017 Apr 1;18(2):197-199. doi: 10.1093/biostatistics/kxw031. Biostatistics. 2017. PMID: 27780809 Free PMC article.
22 results